clinical applications cannabis terpenes

Clinical Application of Cannabinoids and Terpenes | M. Gordon,

The complexity of medical cannabis stems from the millions of combinations of doses and cannabinoid/terpene profiles. Despite this challenge, a systematic and intelligent approach can lead to informed recommendations that most benefit patients. Over time as more research is gathered, these recommendations will become progressively more robust, leading to higher levels of satisfaction with the first recommendation.

Understanding Endocannabinoid System video

Understanding the Endocannabinoid System

More importantly, modulating the activity of the endocannabinoid system turned out to hold therapeutic promise in a wide range of disparate diseases and pathological conditions, ranging from mood and anxiety disorders, movement disorders such as Parkinson’s and Huntington’s disease, neuropathic pain, multiple sclerosis and spinal cord injury, to cancer, atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma, obesity/metabolic syndrome, and osteoporosis, to name just a few.

HB 269 Texas 2017

Applying Science to Senate Bill No. 269 in Texas | Medical Marijuana Bill 2017

Wording taken From: 85R1145 GCB-F By:  Menéndez                                                                                                                                            S.B. No. 269 A BILL TO BE ENTITLED AN ACT (A)….. (The following… Read more Applying Science to Senate Bill No. 269 in Texas | Medical Marijuana Bill 2017

synergistic responses between cannabidiol DNA damaging agents

Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture

Liting Deng, Lindsay Ng, Tatsuya Ozawa and Nephi Stella Journal of Pharmacology and Experimental Therapeutics November 7, 2016, jpet.116.236968; DOI:… Read more Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture